G6PD and head and neck squamous cell carcinoma: A combination of Cisplatin, the standard chemotherapy for HNSCC, with G6PD inhibitors such as DHEA, trans-polydatin, or 6-aminonicotinamide (6-AN), demonstrated synergistic cytotoxic effects [19].